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This study aimed at identifying potential microRNAs that modulate hepatic lipid droplets (LD)
through targeting the Tail interacting protein of 47kDa (TIP47) in HCV infection.
Bioinformatics analysis revealed that miR-148a and miR-30a potentially target TIP47. Expression
proﬁling showed that both microRNAs were downregulated, while TIP47 was upregulated in liver
biopsies of HCV-infected patients. Forcing the expression of both microRNAs in JFH-I infected, oleic
acid-treated Huh7 cells, signiﬁcantly suppressed TIP47 expression and reduced cellular LDs with
marked decrease in viral RNA. This study shows that miR-148a and miR-30a, regulate TIP47 expres-
sion and LDs in HCV infected cells.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The accumulation of lipid droplets (LDs) in the liver of HCV
infected patients suggests an association between HCV infection
and numerous disorders of lipid metabolism [1,2]. Moreover, cul-
tured cells infected with HCV showed a high LD content [3].
Various viral components important for the production of new viri-
ons were found to accumulate at the surface of lipid droplets, such
as the core protein, NS5A as well as +ve andve RNA strands [3–6].
Disruption of the association of core protein or NS5A to LDs pre-
vents the assembly and production of infectious viral particles,
which highlights the importance of the HCV–LD interaction in
the viral life cycle [3,7].Proteins associated to LDs surface, regulating their structure
and function, include the family of PAT proteins, named after its
three ﬁrst discovered members, Perilipin, Adipocyte
differentiation-related protein (ADRP), and Tail-interacting protein
of 47 kilo Daltons (TIP47), in addition to S3-12 and OXPAT/MLDP
[8–10]. The expression of PAT proteins is affected by HCV infection.
In HCV core expressing cells, ADRP was found to be signiﬁcantly
lower, while TIP47 was signiﬁcantly higher compared to cells that
are not expressing the core protein [5]. However, another study
showed that TIP47 protein levels were lower in HCV replicating
cells compared to control cells, while its mRNA expression was
higher [11]. While HCV alters TIP47 expression, TIP47 in turn is
essential for HCV life cycle. Overexpression of TIP47 increased
replication and release of HCV particles, while it’s silencing mark-
edly decreased the release of infectious particles. The interaction
between HCV and TIP47 was reported to be through the associa-
tion of NS5A to the N-terminus of TIP47 [11,12]. This interaction
possibly integrates LD membranes into the HCV membranous
web, facilitating HCV replication and assembly [12]. TIP47 was
even found to associate to the released viral particle [13].
Recently, HCV was shown to induce hepatic LD accumulation by
suppressing peroxisome proliferator-activated receptor (PPAR)-a
and angiopoietin-like protein 3 (ANGPTL3), known regulators of
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induced upregulation of miR-27b, representing a novel mechanism
contributing to the development of HCV induced hepatic steatosis
[14]. Moreover, miR-27a was found to suppress HCV infection as
well as cellular lipid storage in Huh7.5 cells through targeting
and suppressing various lipogenic genes [15]. These data show that
there is a noticeable interplay between HCV, lipid droplets along
with their associated PAT proteins, and microRNAs. To date only
very limited data concerning the role of microRNAs in regulating
lipid droplets through regulating PAT proteins exist. Hence, this
study aimed at examining the effect of microRNAs on hepatic
TIP47 expression in an attempt to suppress hepatic lipid droplet
formation and subsequently HCV infection.
2. Patients and methods
2.1. Patients
Liver needle biopsies were taken from 21 chronic HCV patients.
All patients included are HBV negative and did not receive any
treatment. Healthy liver biopsies were obtained from nine donors
during liver transplantation. All patients were recruited from Al
Kasr Al Aini Hospital, Cairo University Medical School. The study
followed the ethical guidelines of the 1975 Declaration of
Helsinki. Informed consent was obtained from all patients included
in the study. Clinical parameters of the patients are presented in
Table 1.
2.2. Cell culture
Human Hepatocellular Carcinoma cells (Huh-7) were cultured
in Dulbecco’s modiﬁed Eagle’s medium (DMEM) supplemented
with 4.5 g/L Glucose, L-Glutamine, 1% Penicillin/Streptomycin and
10% Fetal Bovine Serum (FBS). Cells were incubated in a CO2 incu-
bator adjusted to 5% CO2 at 37 C.
2.3. In-vitro transcription and transfection of HCV RNA
pJFH-I harboring the full-length HCV genotype 2a genome
(kindly provided by Prof. Wakita) was used to generate HCV repli-
con cells. Brieﬂy, pJFH-I was linearized using XbaI restriction
enzyme, followed by puriﬁcation of linearized DNA with phe-
nol/chloroform. 1 lg of puriﬁed DNA was in vitro transcribed usingTable 1
Patients’ clinical data.
Patient # Age Gender VL ALT AST Metavir score
P1 43 M 117744 28 30 F1
P2 37 M 1180492 74 74 F1
P3 36 M 215500 80 62 F1
P4 28 F 169000 32 25 F1
P5 28 M 106000 58 37 F1
P6 50 M 1060000 56 60 F2
P7 35 F 1650000 18 21 F3
P8 25 M 45190 105 55 F1
P9 47 M 3230000 26 28 F3
P10 28 F 119000 33 26 F4
P11 46 M 1654000 78 101 F3
P12 55 M 179000 76 80 F3
P13 32 M 3120000 52 47 F1
P14 35 M 4020000 74 65 F1
P15 34 M 1790000 62 53 F1
P16 52 M 1120000 34 53 F4
P17 68 F 15432000 54 43 F2
P18 34 M 403200 42 55 F1
P19 40 F 53200000 60 44 F1
P20 38 F 7670000 15 18 F1
P21 56 F 56300 67 53 F4MEGAscript T7 Transcription Kit (Ambion, USA) yielding full
length HCV RNA. 10 lg of HCV RNA were transfected into Huh7
cells using Superfect transfection reagent. 3 days post transfection,
cell culture supernatant was collected, ﬁltered using 0.45 lm ﬁlter
and stored at 80 C for later infection of naïve Huh7 cells.
2.4. RNA extraction and quantiﬁcation
Total RNA was extracted from liver biopsies or Huh7 cells using
Biozol reagent according to the manufacturer’s instructions (Bioer
Technology, China). The relative expression of TIP47 was quanti-
ﬁed relative to the housekeeping gene b2-microglobulin (B2M)
and the relative expression of miR-148a and miR-30a were quanti-
ﬁed relative to the housekeeping gene RNU6B using TaqMan
real-time quantitative polymerase chain reaction (PCR) (StepOne,
Applied Biosystems).
2.5. Transfection of oligos
Huh7 cells were transfected with 25 nM mimics, antagomirs or
siRNAs using Hiperfect transfection reagent (Qiagen) according to
the manufacturer’s instructions. Transfection was performed in
96-well plates for TIP47 mRNA quantiﬁcation, intracellular LDs
imaging and viral RNA quantiﬁcation or in 24-well plates to exam-
ine TIP47 protein expression.
2.6. Fatty acid treatment
24 h post transfection with oligos; lipid loading of Huh7 cells
was achieved by incubating the cells with 600 lM bovine serum
albumin-coupled oleic acid (OA) (Sigma Aldrich). Cells were either
harvested 48 h. after OA treatment for viral load and TIP47 mRNA
quantiﬁcation or after 72 h for LDs staining or protein expression
examination using western blotting.
2.7. Western blotting
Cells were washed with PBS and proteins were extracted using
laemmli buffer. Protein concentration was measured using
Modiﬁed Lowry Protein Assay Kit, (Pierce Biotechnology, Inc.)
according to the manufacturer’s instructions. 30 lg of proteins
were separated using SDS–PAGE. Proteins were transferred to
nitrocellulose membrane and the expression of TIP47 and b-actin
was evaluated using mouse anti-TIP47 (B3) antibody and mouse
anti-b-actin (C4) antibody (Santa Cruz Biotechnology Inc., USA),
respectively. Goat anti-mouse IgG-HRP (Santa Cruz Biotechnology
Inc., USA) along with TMB Membrane Peroxidase Substrate
System (KPL Inc., USA) was used for colorimetric detection of the
protein bands.
2.8. Lipid droplet staining
A 0.35% oil-red-O (ORO) stock solution (Serva, Germany) was
prepared and ﬁltered using a 0.22 lm ﬁlter. A working solution
of ORO was freshly prepared by diluting the stock solution with
double distilled water at a 6:4 ratio, was left to stand for 20 min
and ﬁltered using a 0.22 lm ﬁlter. Cultured cells were ﬁxed with
4% formaldehyde in PBS for 10 min. Fixed cells were washed with
3 changes of PBS. Cells were permeabilized by incubating with
0.05% Tween 20 in PBS for 15 min followed by 3 washes with
PBS then once with 60% isopropanol. Afterwards, cells were incu-
bated with ORO working solution for 10 min followed by 4 washes
with distilled water and then mounted with a mounting solution
containing DAPI to stain the cell nuclei. LDs and nuclei were visu-
alized using ﬂuorescence microscopy with a 100 objective
(Axiom Zeiss).
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Isolation of the viral RNA frommammalian cells was done using
Invisorb Spin Virus RNA Mini Kit (Invitek) according to the manu-
facturers’ instruction. Viral nucleic acid was quantiﬁed using viral
nucleic acid detection kit (Genesig, Primer design, UK) according
to manufacturer’s protocol. Absolute quantiﬁcation was calculated
according to standards of known quantities.
2.10. Luciferase reporter assay
The pmirGLO vector (Promega) was used to validate the binding
of miR-148a and miR-30a to the 30UTR of TIP47. The binding region
of miR-148a and miR-30a in the 30UTR of TIP47 were designed
with sticky ends of SacI and XbaI restriction sites. Sense and anti-
sense oligonucleotides of miR-148a (sense: 50-CTCAGCGGGCCCCG
TCTCTATAATGCAGCTGTGCTCTGGAT-30, antisense: 50-CTAGATCC
AGAGCACAGCTGCATTATAGAGACGGGGCCCGCTGA GAGCT-30) or
miR-30a (sense: 50-CTAGTTCATATCCCACTTCTTTGTTTACACCGA
TT-30, antisense 50-CTAGAATCGGTGTAAACAAAGAAGTGGGATATG
AACTAGAGCT-30) binding regions were annealed and cloned into
pmirGLO vector between SacI and XbaI restriction sites
(WT-148 and WT-30, respectively). A mutant type vector of each
binding region with deletion of the region complementary to the
seed sequence of each of the miRNAs in the 30UTR of TIP47
(underlined in the above sequences) was constructed (Mut-148
and Mut-30).
Huh7 cells were transfected with 1 lg of either WT-148,
Mut-148, WT-30 or Mut-30 vectors using Superfect transfection
reagent (Qiagen). After 24-h cells were transfected with
miR-148a or miR-30a mimics using Hiperfect transfection reagent
(Qiagen). 48-h post transfection luciferase activity was measured
using Steady-Glo luciferase Assay system (Promega).Fig. 1. Expression proﬁle of TIP47, miR-148a and miR-30a in liver biopsies of HCV infect
biopsies compared to healthy controls (3.660 ± 1.201, N = 9). (B) miR-148a (0.7188 ± 0.2
downregulated in HCV infected patients compared to healthy controls (3.345 ± 1.814, N2.11. Statistical analysis
Data are expressed as mean ± standard error of the mean and
were analyzed using Student T test using GraphPad Prism 5. P val-
ues lower than 0.05 were considered statistically signiﬁcant.
3. Results
3.1. Bioinformatics analysis
Potential microRNAs that target the 30 untranslated region
(30UTR) of TIP47 were identiﬁed using the bioinformatics tools
miRanda, TargetScan and mirDIP. Selection of microRNAs to be
investigated in this study was based on their predicted mirSVR
binding scores to TIP47. mirSVR scoring takes into account various
features of the predicted miRNA:mRNA duplex, including base
pairing at the seed region, A/U composition near the target sites,
secondary structure accessibility, length of the UTR and relative
position of the target site in the UTR. mirSVR scores correlate lin-
early with the extent of downregulation with a suggested score
cutoff of 0.1 or lower [16]. MicroRNAs that showed potential
binding were compared with the results of a high content assay,
performed by Whittaker and colleagues that identiﬁed
microRNAs that regulate LDs in human hepatocytes [17]. Based
on that, miR-30a-5p and miR-148a-3p were selected. miR-30a-5p
was found to target the 30UTR of TIP47 with a mirSVR score of
1.0251, while miR-148a-3p showed a mirSVR score of 0.1210.
3.2. Expression proﬁle of TIP47, miR-148a and miR-30a in liver
biopsies of HCV infected patients compared to healthy controls
Expression proﬁle of TIP47, miR-148a and miR-30a was investi-
gated in liver biopsies of HCV infected patients compared to
healthy controls. TIP47 was found to be upregulateded patients. (A) TIP47 is upregulated (7.634 ± 1.419, N = 21, P = 0.0489⁄) in HCV liver
852, N = 21, P = 0.0216⁄) and (C) miR-30a (0.5408 ± 0.1183, N = 21, P = 0.0041⁄⁄) are
= 9) and (1.442 ± 0.3492, N = 9), respectively. Results are expressed as mean ± S.E.M.
Fig. 2. Impact of HCV infection on TIP47, miR-148a and miR-30a expression in Huh7 cells. Infection of Huh7 cells with HCVcc-JFH-I lead to (A) induction of TIP47 expression
(3.431 ± 1.027, P = 0.0167⁄) compared to uninfected cells (1.001 ± 0.02294) and suppression of (B) miR-148a (0.1418 ± 0.004423, P = 0.0172⁄) and (C) miR-30a
(0.3201 ± 0.01441, P = 0.0353⁄) compared to naïve cells (1.019 ± 0.1416) and (1.009 ± 0.1321), respectively. Results are expressed as mean ± S.E.M., n = 4.
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(P = 0.0216⁄ and P = 0.0041⁄⁄, respectively) in HCV patients (Fig. 1).
3.3. Expression proﬁle of TIP47, miR-148a and miR-30a in JFH-1
infected Huh7 cell lines
To conﬁrm that the observed alteration in TIP47 and microRNAs
expression in patients’ biopsies is due to HCV infection, Huh7 cells
were infected with HCVcc-JFH-I and TIP47, miR-148a and miR-30a
expression was compared to uninfected cells. Infection of Huh7 cell
lines resulted in induction of TIP47 (P = 0.0167⁄) and suppression
of miR-148a and miR-30a expression compared to uninfected cells
(Fig. 2).
3.4. Impact of manipulating miR-148a and miR-30a on TIP47 mRNA &
protein expression
miR-148a and miR-30a mimics or antagomirs were transfected
3 days post infection of Huh7 cells with JFH-I. siRNAs against TIP47
were also transfected as a positive control. 24-h post transfection,
cells were treated with OA to induce LD formation. 48 h and 72 h
post OA treatment TIP47 mRNA and protein expression, respec-
tively, was examined. Efﬁcient transfection of mimics was con-
ﬁrmed by measuring microRNA expression in transfected
compared to mock cells, where miR-148a increased by a mean of
800 folds (P = 0.0232⁄), while miR-30a expression was increased
by a mean of 1500 folds (P = 0.0002⁄⁄⁄) in mimicked compared to
mock cells (Fig. 3A and B).
miR-148a and miR-30a mimics suppressed TIP47 mRNA
(P = 0.0488⁄ and P = 0.0262⁄, respectively) and protein expression
compared to untransfected cells (1.017 ± 0.09644). miR-148a and
miR-30a antagomirs did not signiﬁcantly affect TIP47mRNA or pro-
tein expression. siRNAs against TIP47 efﬁciently suppressed its
mRNA(P = 0.0002⁄⁄⁄) andproteinexpression (Fig.3CandD;SI Fig.1).3.5. Validation of miR-148a and miR-30a binding to 30UTR of TIP47
To validate that miR-148a and miR-30a induce their suppres-
sive effects on TIP47 by directly binding to its 30UTR, wild type
or mutant binding regions of miR-148a or miR-30a were cloned
downstream of luciferase reporter gene in pmirGLO vector
(Fig. 4A and B). The designed constructs were transfected in
Huh7 cells followed by transfection of miR-148a or miR-30a mim-
ics. Luciferase activity was measured 48 h post transfection.
miR-148a mimics suppressed luciferase activity in cells harboring
the miR-148a wild type construct (WT-148) (P = 0.0194⁄) but did
not affect the activity in cells harboring the mutant vector
(Mut-148) (Fig. 4C). Similarly, miR-30a mimics suppressed lucifer-
ase activity in cells harboring wild type miR-30a vector (WT-30)
(P = 0.04138⁄) but not the mutant type (Mut-30) (Fig. 4D).
3.6. Impact of manipulating miR-148a and miR-30a expression on
cellular lipid droplet content
The effect of manipulating miR-148a and miR-30a on cellular
lipid droplets was studied by staining LDs with oil-red-O dye and
visualizing them using ﬂuorescence microscopy. Cellular lipid dro-
plet content decreased upon transfection of miR-148a and miR-30a
mimics, while their antagomirs did not markedly affect the cellular
LDs. TIP47 siRNAs also decreased LD levels (Fig. 5).
3.7. Impact of manipulating miR-148a and miR-30a expression on
HCV JFH-I viral load
Forcing the expression of miR-148a and miR-30a lead to a mean
decrease of 36% (P = 0.0401⁄) and 50% (P = 0.0475⁄), respectively, in
the viral load (VL) in JHF-I infected, OA treated Huh7 cells com-
pared to mock cells. The VL was not signiﬁcantly affected upon
antagonizing either miR-148a or miR-30a. Knock down of TIP47
Fig. 3. Impact of manipulating miR-148a and miR-30a on TIP47 mRNA and protein expression in JFH-I infected Huh7 cells. Efﬁcient delivery of miR-148a (A) and miR-30a (B)
mimics into Huh7 cells was conﬁrmed by measuring microRNA relative quantity in transfected compared to untransfected cells. miR-148a increased by 800 folds and miR-
30a increased by 1500 folds in mimicked compared to untransfected cells. (C) miR-148a and miR-30a mimics suppressed TIP47 mRNA expression (0.6906 ± 0.1489,
P = 0.0488⁄) and (0.7016 ± 0.06406, P = 0.0262⁄), respectively, compared to mock cells (1.017 ± 0.09644). siRNAs against TIP47 efﬁciently suppressed its expression
(0.2910 ± 0.05208, P = 0.0002⁄⁄⁄). Results are expressed as mean ± S.E.M., n = 5. (D) Protein expression of TIP47 was suppressed by miR-148a (0.87), miR-30a (0.69) and TIP47
siRNAs (0.64). Results are expressed as relative density of TIP47 bands compared to mock cells.
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(Fig. 6).
4. Discussion
Lipid droplets act as an assembly platform for HCV and thus
play an important role in the viral life cycle [3,18]. LDs formation
and stabilization is controlled by a number of proteins associated
to their surfaces among which are the PAT proteins [19,20].
Alteration in cellular LD content as well as their associated PAT
protein, TIP47, was previously shown to affect HCV replication
and assembly [5,11,12]. However, the regulation of PAT proteins
by microRNAs and how they would affect HCV infection has never
been investigated. Thus, this study focused on investigating the
microRNA regulation of hepatic TIP47 expression, in an attempt
to decrease LDs and subsequently attenuate HCV infection.
MicroRNAs that potentially target TIP47 were identiﬁed using
bioinformatics analysis. In 2010, a group in California performed
a high content screening assay to identify microRNAs that regulate
hepatic LDs [17]. To select microRNAs to be investigated in this
study, the results of the bioinformatics analysis were compared
to those of the high content screen. Two microRNAs, miR-148a
and miR-30a were selected for this study as they were shown by
bioinformatics to target TIP47 and were also reported by the
Whittaker study to regulate LDs [17]. The impact of HCV infection
on hepatic TIP47 and microRNA expression was investigated bymeasuring their expression in liver biopsies of HCV infected
patients and healthy controls using qRT-PCR. TIP47 was found to
be upregulated (Fig. 1A), while miR-148a and miR-30a were down-
regulated (Fig. 1B and C) in HCV infected biopsies. However, no
correlation was observed between the expression of TIP47 and
either of the microRNAs. To conﬁrm that the observed alteration
in TIP47 and microRNA expression in liver biopsies is due to HCV
infection, the impact of infecting Huh7 cells with HCVcc-JFH-I on
TIP47, miR-148a and miR-30a expression was investigated.
Interestingly, the same expression pattern as in liver biopsies of
HCV infected patients was observed, where TIP47 was induced,
while miR-148a and miR-30a were suppressed upon infection of
Huh7 cells (Fig. 2). These results are in accordance with a study
that reported that TIP47 expression was higher in HepG2 cells
expressing HCV core protein compared to cells not expressing
the core protein [5]. Another study showed that TIP47 mRNA
expression was higher in HCV infected Huh7.5 cells as well as pri-
mary hepatocytes [11].
Since miR-148a and miR-30a were downregulated in HCV
infected patients, it was interesting to examine whether correcting
their expression using speciﬁc oligos would affect the expression of
their predicted downstream target TIP47. Hence, JFH-I infected
Huh7 cells were transfected with miR-148a or miR-30a mimics
or antagomirs or speciﬁc siRNAs against TIP47 as a positive control.
24 h after transfection, cells were treated with OA, an inducer of
LDs, to determine the effect of both microRNAs on LD formation.
Fig. 4. Validation of miR-148a and miR-30a binding to 30UTR of TIP47. (A) Sequence alignment of miR-148a and the 30 UTR of TIP47 and the construction of pmirGLO vector
harboring either wild type miR-148a binding region (WT-148) or a mutant type binding region in which the seed region of miR-148a was deleted (Mut-148). (B) Sequence
alignment of miR-148a and the 30 UTR of TIP47 and the construction of pmirGLO vector harboring either wild type miR-30a binding region (WT-30) or a mutant type binding
region in which the seed region of miR-30a was deleted (Mut-30). (C) miR-148a mimics suppressed the luciferase activity in cells harboring WT-148 vector (P = 0.0194⁄), but
did not affect its activity in cells harboring Mut-148. (D) miR-30a mimics suppressed the luciferase activity in cells harboring WT-30 vector (P = 0.0413⁄), but did not affect its
activity in cells harboring Mut-30. Results are expressed as mean ± S.E.M., n = 3.
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respectively, post OA treatment. Interestingly, both miR-148a
and miR-30a mimics suppressed TIP47 expression on the mRNA
and protein level (Fig. 3C and D; SI Fig. 1). This shows that TIP47
could indeed be a downstream target of both microRNAs as pre-
dicted by bioinformatics. Thus, the direct targeting of miR-148a
and miR-30a to TIP47 30UTR was investigated and conﬁrmed
through performing luciferase reporter assay, where miR-148a
and miR-30a suppressed luciferase activity in cells transfected
with pmirGLO vector harboring miR-148a or miR-30a binding
regions on TIP47 30UTR (Fig. 4C and D).
The impact of manipulating miR-148a and miR-30a on cellular
LDs was then examined by staining LDs with oil-red-O 72 h postOA treatment. miR-148a and miR-30a mimics decreased LDs com-
pared to mock cells, which was also observed in TIP47 knockdown
cells (Fig. 5). This decrease in LDs could be in part due to suppres-
sion of TIP47, since previous reports showed that TIP47 is involved
in LD biogenesis and that knock down of TIP47 inhibited growth
and maturation of LDs [21]. Moreover, in vivo tests showed that
knock down of TIP47 using antisense oligonucleotides improved
hepatic steatosis in high-fat fed mice [22].
Since LDs were repeatedly reported to play an important role
in HCV life cycle, it was intriguing to investigate whether the
decrease in LDs and TIP47 in response to forcing the expression
of miR-148a and miR-30a would also repress HCV replication.
Interestingly, miR-148a and miR-30a mimics were found to
Fig. 5. Impact of miR-148a and miR-30a on cellular LDs. miR-148a and miR-30a mimics decreased LDs in Huh7, OA treated cells compared to mock cells. miR-148a and miR-
30a antagomirs did not markedly affect LDs. TIP47 siRNAs lead to a decrease in cellular LDs. Red ﬂuorescence represents lipid droplets stained with oil-red-O. Blue
ﬂuorescence represents the cell nuclei stained with DAPI. Scale bars are equal to 10 lm.
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viral RNA in response to miRNA mimics was similar to the
decrease induced by TIP47 siRNAs, where TIP47 knockdown lead
to a 49% decrease in viral RNA (Fig. 6). These ﬁndings go alongwith two recent studies, which showed that knockdown of
TIP47 resulted in a marked suppression of HCV replication and
release of infectious viral particles [11,12]. Similar to our ﬁnd-
ings, another study showed that overexpression of miR-27a
Fig. 6. Impact of manipulating miR-148a and miR-30a expression on HCV JFH-I
viral load. Effect of manipulating miR-148a and miR-30a in JFH-I infected, OA
treated cells on the intracellular viral load was examined. miR-148a and miR-30a
mimics decreased the VL by 36% (456.3 ± 52.55, P = 0.0401⁄) and 50%
(355.1 ± 77.95, P = 0.0475⁄), respectively, compared to mock cells (711.5 ± 37.50).
miR-148a and mir-30a antagomirs did not affect the VL signiﬁcantly. TIP47
knockdown decreased VL by a mean of 49% (362.3 ± 84.50, P = 0.0291⁄) compared to
mock cells. Results are expressed as mean ± S.E.M., n = 5.
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cells [15].
In conclusion the collective ﬁndings of this study show that
HCV infection induces hepatic TIP47 expression. Moreover, HCV
infection suppresses miR-148a and miR-30a expression. Forcing
the expression of miR-148a and miR-30a suppressed TIP47
mRNA and protein expression and hence decreased cellular LDs
as well as intracellular HCV RNA. Thus, miR-148a and miR-30a
reversed the effects induced by HCV infection and could be used
as potential therapeutic targets to attenuate HCV infection and
treat hepatic steatosis induced by HCV.
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